United States
Germany
Japan
United Kingdom
China
FXYD3 (NM_001136007) Human Tagged ORF Clone Lentiviral Particle
CAT＃: RC227092L4V
- LentiORF®
-
Lenti ORF particles, FXYD3 (mGFP-tagged)-Human FXYD domain containing ion transport regulator 3 (FXYD3), transcript variant 3, 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 8,360.00
Product images
CNY 1,999.00
CNY 2,700.00
Specifications
| Product Data | |
| Product Name | FXYD3 (NM_001136007) Human Tagged ORF Clone Lentiviral Particle |
| Synonyms | MAT8; PLML |
| Vector | pLenti-C-mGFP-P2A-Puro |
| ACCN | NM_001136007 |
| ORF Size | 432 bp |
| Sequence Data |
The ORF insert of this clone is exactly the same as(RC227092).
|
| OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
| OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
| Reference Data | |
| RefSeq | NM_001136007.1 |
| RefSeq ORF | 435 bp |
| Locus ID | 5349 |
| Protein Families | Ion Channels: Other, Transmembrane |
| MW | 15 kDa |
| Gene Summary | This gene belongs to a small family of FXYD-domain containing regulators of Na+/K+ ATPases which share a 35-amino acid signature sequence domain, beginning with the sequence PFXYD, and containing 7 invariant and 6 highly conserved amino acids. This gene encodes a cell membrane protein that may regulate the function of ion-pumps and ion-channels. This gene may also play a role in tumor progression. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Oct 2008] |
Documents
| Product Manuals |
| FAQs |
| SDS |
